Stockholders' Deficit (Tables)
|
9 Months Ended |
12 Months Ended |
Mar. 31, 2020 |
Jun. 30, 2019 |
Equity [Abstract] |
|
|
Schedule of Stock Warrant Activity |
Warrant detail for the nine
months ended March 31, 2020 is reflected below:
|
|
Number of
Warrants
|
|
|
Weighted
Average
Exercise
Price Per
Warrant
|
|
|
Remaining
Contract
Term (#
years)
|
|
Warrants outstanding and exercisable at June 30, 2019 |
|
|
8,333 |
|
|
$ |
20.00 |
|
|
|
0.25 |
|
Warrants issued |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants exercised |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants forfeited |
|
|
(8,333 |
) |
|
$ |
20.00 |
|
|
|
- |
|
Warrants outstanding and exercisable at March 31, 2020 |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrant detail for the nine
months ended March 31, 2019 is reflected below:
|
|
Number of
Warrants
|
|
|
Weighted
Average
Exercise
Price Per
Warrant
|
|
|
Remaining
Contract
Term (#
years)
|
|
Warrants outstanding and exercisable at June 30, 2018 |
|
|
174,079 |
|
|
$ |
20.30 |
|
|
|
0.74 |
|
Warrants issued |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants exercised |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants exchanged |
|
|
(165,746 |
) |
|
$ |
20.30 |
|
|
|
- |
|
Warrants forfeited |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants outstanding and exercisable at March 31, 2019 |
|
|
8,333 |
|
|
$ |
20.00 |
|
|
|
0.50 |
|
|
Warrant detail for the
year ended June 30, 2019 is reflected below:
|
|
Number of
Warrants
|
|
|
Weighted
Average
Exercise
Price Per
Warrant
|
|
|
Remaining
Contract
Term (# years)
|
|
Warrants outstanding and exercisable at June 30, 2018 |
|
|
174,079 |
|
|
$ |
20.30 |
|
|
|
0.74 |
|
Warrants issued |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants exchanged |
|
|
(7,996 |
) |
|
|
14.80 |
|
|
|
- |
|
Warrants forfeited |
|
|
(157,750 |
) |
|
$ |
19.93 |
|
|
|
- |
|
Warrants outstanding and exercisable at June 30, 2019 |
|
|
8,333 |
|
|
$ |
20.00 |
|
|
|
0.25 |
|
Warrant detail for year
ended June 30, 2018 is reflected below:
|
|
Number of
Warrants
|
|
|
Weighted
Average
Exercise
Price Per
Warrant
|
|
|
Remaining
Contract
Term (# years)
|
|
Warrants outstanding and exercisable at June 30, 2017 |
|
|
234,259 |
|
|
$ |
19.70 |
|
|
|
0.12-1.55 |
|
Warrants issued |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Warrants exchanged |
|
|
(14,165 |
) |
|
$ |
6.00 |
|
|
|
- |
|
Warrants forfeited |
|
|
(46,015 |
) |
|
$ |
21.50 |
|
|
|
- |
|
Warrants outstanding and exercisable at June 30, 2018 |
|
|
174,079 |
|
|
$ |
20.30 |
|
|
|
0.74 |
|
|
Schedule of Stock Options Activity |
Activity in stock options
during the nine months ended March 31, 2020, and related balances outstanding as of that date are reflected below:
|
|
Number of Shares |
|
|
Weighted Average Exercise
Price |
|
|
Weighted Average Remaining Contract Term (# years) |
|
Outstanding at June 30, 2019 |
|
|
580,171 |
|
|
$ |
11.05 |
|
|
|
8.59 |
|
Granted |
|
|
15,792 |
|
|
$ |
8.87 |
|
|
|
|
|
Exercised |
|
|
(5,249 |
) |
|
$ |
4.68 |
|
|
|
|
|
Forfeited and cancelled |
|
|
(8,718 |
) |
|
$ |
12.56 |
|
|
|
|
|
Outstanding at March 31, 2020 |
|
|
581,996 |
|
|
$ |
11.02 |
|
|
|
7.87 |
|
Exercisable at March 31, 2020 |
|
|
414,720 |
|
|
$ |
10.65 |
|
|
|
7.53 |
|
Activity in stock options
during the nine months ended March 31, 2019, and related balances outstanding as of that date are reflected below:
|
|
Number of Shares |
|
|
Weighted Average Exercise
Price |
|
|
Weighted Average Remaining Contract Term (# years) |
|
Outstanding at June 30, 2018 |
|
|
354,447 |
|
|
$ |
8.30 |
|
|
|
8.87 |
|
Granted |
|
|
247,896 |
|
|
$ |
14.40 |
|
|
|
|
|
Exercised |
|
|
- |
|
|
$ |
- |
|
|
|
|
|
Forfeited and cancelled |
|
|
(18,366 |
) |
|
$ |
4.60 |
|
|
|
|
|
Outstanding at March 31, 2019 |
|
|
583,977 |
|
|
$ |
11.00 |
|
|
|
8.78 |
|
Exercisable at March 31, 2019 |
|
|
266,919 |
|
|
$ |
9.60 |
|
|
|
7.98 |
|
|
Activity in stock options
during the year ended June 30, 2019 and related balances outstanding as of that date are reflected below:
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted
Average
Remaining
Contract
Term (# years)
|
|
Outstanding at June 30, 2018 |
|
|
350,726 |
|
|
$ |
8.38 |
|
|
|
8.87 |
|
Granted |
|
|
245,027 |
|
|
$ |
14.45 |
|
|
|
9.71 |
|
Exercised |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Forfeited and cancelled |
|
|
(15,582 |
) |
|
$ |
4.64 |
|
|
|
- |
|
Outstanding at June 30, 2019 |
|
|
580,171 |
|
|
$ |
11.05 |
|
|
|
8.59 |
|
Exercisable at June 30, 2019 |
|
|
303,611 |
|
|
$ |
10.02 |
|
|
|
8.01 |
|
Activity in stock options
during the year ended June 30, 2018 and related balances outstanding as of that date are reflected below:
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted
Average
Remaining
Contract
Term (# years)
|
|
Outstanding at June 30, 2017 |
|
|
71,628 |
|
|
$ |
11.00 |
|
|
|
7.09 |
|
Granted |
|
|
292,511 |
|
|
$ |
7.80 |
|
|
|
- |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited and cancelled |
|
|
(13,413 |
) |
|
$ |
4.60 |
|
|
|
- |
|
Outstanding at June 30, 2018 |
|
|
350,726 |
|
|
$ |
8.38 |
|
|
|
8.87 |
|
Exercisable at June 30, 2018 |
|
|
139,169 |
|
|
$ |
7.30 |
|
|
|
7.70 |
|
|
Schedule of Stock-Based Compensation Expenses |
The Company allocated stock-based
compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee
option grants as follows:
|
|
For the Three Months Ended March 31 |
|
|
For the Nine Months Ended March 31, |
|
|
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
Research and development |
|
$ |
54,000 |
|
|
$ |
225,000 |
|
|
$ |
162,000 |
|
|
$ |
256,000 |
|
General and administration |
|
|
402,000 |
|
|
|
861,000 |
|
|
|
1,194,000 |
|
|
|
1,236,000 |
|
Total stock-based compensation expense |
|
$ |
456,000 |
|
|
$ |
1,086,000 |
|
|
$ |
1,356,000 |
|
|
$ |
1,492,000 |
|
|
We allocated stock-based
compensation expense included in the consolidated statements of operations for employee option grants and non-employee option grants
as follows:
Years ended June 30, |
|
2019 |
|
|
2018 |
|
Research and development |
|
$ |
314,000 |
|
|
$ |
96,000 |
|
Selling and administrative |
|
|
1,630,000 |
|
|
|
159,000 |
|
Total stock-based compensation expense |
|
$ |
1,944,000 |
|
|
$ |
255,000 |
|
|
Schedule of Fair Value Assumptions of Stock Options |
The fair value of stock
options was measured at the grant date using the assumptions (annualized percentages) in the table below:
Nine months ended March 31, |
|
2020 |
|
|
2019 |
|
Expected volatility |
|
|
100.60 |
% |
|
|
111 |
% |
Risk free interest rate |
|
|
1.73 |
% |
|
|
2.10 |
% |
Forfeiture rate |
|
|
20.0 |
% |
|
|
20.0 |
% |
Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
Expected term (years) |
|
|
5.56 |
|
|
|
5 |
|
|
The fair value of stock
options was measured at the grant date using the assumptions (annualized percentages) in the table below:
|
|
2019 |
|
|
2018 |
|
Expected volatility |
|
111.4% -112.2% |
|
|
138% -143% |
|
Risk free interest rate |
|
2.43% - 2.45% |
|
|
1.76% - 2.63% |
|
Forfeiture rate |
|
20% |
|
|
20% -23% |
|
Dividend yield |
|
0% |
|
|
0% |
|
Expected term (years) |
|
5.61 |
|
|
5 |
|
|